Analysis of Antigen Expression in T-Cell Acute Lymphoblastic Leukemia by Multicolor Flow Cytometry: Implications for the Detection of Measurable Residual Disease
International Journal of Molecular Sciences · 25.02.2025 · 26 (5) · 2002
DOI: 10.3390/ijms26052002 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.02.2025. Verfasst von Alexandra Semchenkova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 1 Samory Mashela St., Moscow 117198, Russia. Hauptthemen laut MEDLINE: Flow Cytometry, Neoplasm, Residual, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Antigens, CD. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Multicolor flow cytometry (MFC) is a key method for assessing measurable residual disease (MRD) in acute lymphoblastic leukemia (ALL). However, very few approaches were developed for MRD in T-cell ALL (T-ALL). To identify MRD markers suitable for T-ALL, we analyzed the expression of CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD34, CD45, CD48, CD56, CD99, and HLA-DR in T-ALL patients at diagnosis. The median fluorescence intensities (MFIs) of surface CD3, CD4, CD5, CD7, CD8, CD45, CD48, CD99, and CD16+CD56 were also evaluated at Day 15 and the end-of-induction (EOI). The MFC data from 198 pediatric T-ALL patients were analyzed retrospectively. At diagnosis, the most common antigens were identified, and the MFI of T-lineage antigens in blasts was compared to that in T lymphocytes. At follow-up, the MFIs of the proposed MRD markers were compared to those observed at diagnosis. The most common T-ALL antigens were CD7 (100.0%), intracellular CD3 (100.0%), CD45 (98.5%), and CD5 (90.9%). The MFIs of T-lineage antigens in blasts differed significantly from those in T lymphocytes. By the EOI, a substantial modulation of sCD3, CD4, CD5, CD7, CD8, and CD45 was observed. CD48 and CD99 were the most stable markers. The proposed MRD markers (sCD3, CD4, CD5, CD7, CD8, CD45, CD48, CD99, CD16+CD56) enabled MFC-MRD monitoring in virtually all T-ALL patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 1 Samory Mashela St., Moscow 117198, Russia.
ORCID-Profile: Alexandra Semchenkova, Ekaterina Mikhailova, Irina Demina, Alexander Popov
Zitieren
APA
Semchenkova, A., Mikhailova, E., Demina, I., Roumiantseva, J., Karachunskiy, A., Novichkova, G., & Popov, A. (2025). Analysis of Antigen Expression in T-Cell Acute Lymphoblastic Leukemia by Multicolor Flow Cytometry: Implications for the Detection of Measurable Residual Disease. International Journal of Molecular Sciences, 26(5), 2002. https://doi.org/10.3390/ijms26052002
Vancouver
Semchenkova A, Mikhailova E, Demina I, Roumiantseva J, Karachunskiy A, Novichkova G, et al. Analysis of Antigen Expression in T-Cell Acute Lymphoblastic Leukemia by Multicolor Flow Cytometry: Implications for the Detection of Measurable Residual Disease. International Journal of Molecular Sciences. 2025;26(5):2002. doi:10.3390/ijms26052002
BibTeX
@article{Semchenkova2025,
author = {Semchenkova, Alexandra and Mikhailova, Ekaterina and Demina, Irina and Roumiantseva, Julia and Karachunskiy, Alexander and Novichkova, Galina and Popov, Alexander},
title = {Analysis of Antigen Expression in T-Cell Acute Lymphoblastic Leukemia by Multicolor Flow Cytometry: Implications for the Detection of Measurable Residual Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {5},
pages = {2002},
doi = {10.3390/ijms26052002}
}
EUVIMED